Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. EMEA Home Infusion Services Market, By Service Type
7.1. EMEA Home Infusion Services Market, by Service Type, 2021-2030
7.1.1. Pharmaceutical preparation and delivery
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Patient training
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Administration service
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Clinical monitoring
7.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 8. EMEA Home Infusion Services Market, Regional Estimates and Trend Forecast
8.1. Europe
8.1.1. Market Revenue and Forecast, by Service Type (2017-2030)
8.1.2. UK
8.2.2.1. Market Revenue and Forecast, by Service Type (2017-2030)
8.1.3. France
8.2.3.1. Market Revenue and Forecast, by Service Type (2017-2030)
8.1.4. Rest of Europe
8.1.4.1. Market Revenue and Forecast, by Service Type (2017-2030)
Chapter 9. Company Profiles
9.1. OMT GmbH & Co. KG
9.1.1. Company Overview
9.1.2. Product Offerings
9.1.3. Financial Performance
9.1.4. Recent Initiatives
9.2. Licher MT GmbH
9.2.1. Company Overview
9.2.2. Product Offerings
9.2.3. Financial Performance
9.2.4. Recent Initiatives
9.3. Sciensus
9.3.1. Company Overview
9.3.2. Product Offerings
9.3.3. Financial Performance
9.3.4. Recent Initiatives
9.4. Mediq
9.4.1. Company Overview
9.4.2. Product Offerings
9.4.3. Financial Performance
9.4.4. Recent Initiatives
9.5. Hala Healthcare Services
9.5.1. Company Overview
9.5.2. Product Offerings
9.5.3. Financial Performance
9.5.4. Recent Initiatives
9.6. Enayati home healthcare
9.6.1. Company Overview
9.6.2. Product Offerings
9.6.3. Financial Performance
9.6.4. Recent Initiatives
9.7. Orkyn
9.7.1. Company Overview
9.7.2. Product Offerings
9.7.3. Financial Performance
9.7.4. Recent Initiatives
Chapter 10. Research Methodology
10.1. Primary Research
10.2. Secondary Research
10.3. Assumptions
Chapter 11. Appendix
11.1. About Us
11.2. Glossary of Terms